51 NJR 5(2) May 20, 2019 Filed May 2, 2019 HEALTH PUBLIC HEALTH SERVICES BRANCH DIVISION of MEDICINAL MARIJUANA Medicinal Mariju
51 NJR 5(2) May 20, 2019 Filed May 2, 2019 HEALTH PUBLIC HEALTH SERVICES BRANCH DIVISION OF MEDICINAL MARIJUANA Medicinal Marijuana Readoption with Amendments: N.J.A.C. 8:64 Adopted Repeal and New Rule: N.J.A.C. 8:64-5.1 Adopted Repeal: N.J.A.C. 8:64-10.7 Proposed: June 18, 2018, at 50 N.J.R. 1398(a). Adopted: April 26, 2019, by Shereef M. Elnahal, MD, MBA, Commissioner, Department of Health. Filed: April 26, 2019, as R.2019 d.049, with non-substantial changes not requiring additional public notice and comment (see N.J.A.C. 1:30-6.3), and with the proposed amendment at N.J.A.C. 8:64-7.9 not adopted. Authority: N.J.S.A. 24:6I-1 et seq., particularly 24:6I-3, 4, 7, and 16. Effective Dates: April 26, 2019, Readoption; May 20, 2019, Amendments, New Rule, and Repeals. Expiration Date: April 26, 2026. Summary of Public Comments and Agency Responses: The Department received comments from the following: 1. Justin Alpert, Livingston, NJ 2. Rebecca Barnes, Lawrence, NJ 3. Raul Barreiro, Livingston, NJ 4. Chris Beals, President and General Counsel, and Dustin McDonald, Dustin McDonald, Vice President, Government Relations, Weedmaps 5. Kate M. Bell, Esq., Marijuana Policy Project, Washington, DC 6. Mara Brough, Senior Manager of Advocacy, New Jersey and Pennsylvania, National Multiple Sclerosis Society, Woodbridge, NJ 7. Anthony Bennett, Monmouth Junction, NJ 8. Cristina Buccola, Esq., New York, NY 9. Patricia Cancelli, Pennsauken, NJ 10. Aubrey Conway, Parlin, NJ 11. Laurent Crenshaw, Senior Director of Government Affairs, Eaze Solutions Inc., San Francisco, CA 12.
[Show full text]